Literature DB >> 15841927

Menopausal vasomotor symptoms: a review of causes, effects and evidence-based treatment options.

Gloria A Bachmann1.   

Abstract

Vasomotor symptoms are the most common medical complaint of perimenopausal and postmenopausal women. Frequent vasomotor symptoms can be disabling, affecting a woman's social life, psychological health, sense of well-being and ability to work. Women with hot flushes are more likely to experience disturbed sleep, depressive symptoms and significant reductions in quality of life as compared to asymptomatic women. Despite the prevalence and impact of these symptoms, the pathophysiology of hot flushes is unclear; however, estrogen withdrawal clearly plays an important role. It is postulated that declining estrogen concentrations may lead to changes in brain neurotransmitters and instability in the hypothalamic thermoregulatory center. The most effective therapy for relieving vasomotor symptoms and reducing their impact on quality of life is hormone therapy. Other options for women who decline hormone therapy include selective serotonin reuptake inhibitors and related agents. Most herbal therapies that have been evaluated in placebo-controlled trials have shown no clinically significant benefit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841927

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  10 in total

1.  Climacteric Complaints after Breast Cancer - Is HRT an Option?

Authors:  Christian F Singer
Journal:  Breast Care (Basel)       Date:  2008-06-20       Impact factor: 2.860

2.  Factors producing a menopausal depressive-like state in mice following ovariectomy.

Authors:  Naoko Bekku; Hiroyuki Yoshimura; Hiroaki Araki
Journal:  Psychopharmacology (Berl)       Date:  2006-06-21       Impact factor: 4.530

3.  Tissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells.

Authors:  Jaime Kulak; Rui A Ferriani; Barry S Komm; Hugh S Taylor
Journal:  Reprod Sci       Date:  2012-11-20       Impact factor: 3.060

4.  Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function.

Authors:  R W Irwin; J Yao; J To; R T Hamilton; E Cadenas; R D Brinton
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

Review 5.  Safety of aromatase inhibitors in the adjuvant setting.

Authors:  Edith A Perez
Journal:  Breast Cancer Res Treat       Date:  2007-10-03       Impact factor: 4.872

6.  Effects of licorice on relief and recurrence of menopausal hot flashes.

Authors:  Fatemeh Nahidi; Elham Zare; Faraz Mojab; Hamid Alavi-Majd
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

7.  Comparison of Vitex agnus-castus Extracts with Placebo in Reducing Menopausal Symptoms: A Randomized Double-Blind Study.

Authors:  Rozita Naseri; Vahid Farnia; Katayoun Yazdchi; Mostafa Alikhani; Behrad Basanj; Safora Salemi
Journal:  Korean J Fam Med       Date:  2019-05-09

8.  Relationship Between Lifestyle Habits and Health-Related Quality of Life of Recently Diagnosed Breast Cancer Patients: A Comparison Between Younger and Older Women in China.

Authors:  Chao Zheng; Li-Xiang Yu; Hong-Ying Jia; Shu-De Cui; Fu-Guo Tian; Zhi-Min Fan; Cui-Zhi Geng; Xu-Chen Cao; Zhen-Lin Yang; Xiang Wang; Hong Liang; Shu Wang; Hong-Chuan Jiang; Xue-Ning Duan; Hai-Bo Wang; Guo-Lou Li; Qi-Tang Wang; Jian-Guo Zhang; Feng Jin; Jin-Hai Tang; Liang Li; Shi-Guang Zhu; Wen-Shu Zuo; Fei Wang; Fei Zhou; Yu-Juan Xiang; Ming-Ming Guo; Yong-Jiu Wang; Shu-Ya Huang; Li-Yuan Liu; Zhi-Gang Yu
Journal:  Front Public Health       Date:  2021-12-14

9.  Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies.

Authors:  Nathan W Kopper; Jennifer Gudeman; Daniel J Thompson
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Effectiveness of Menosan® Salvia officinalis in the treatment of a wide spectrum of menopausal complaints. A double-blind, randomized, placebo-controlled, clinical trial.

Authors:  Dimpfel Wilfried; Chiegoua Dipah Gwladys Nina; Bommer Silvia
Journal:  Heliyon       Date:  2021-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.